Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer
Conditions
- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
- Urethral Cancer
Interventions
- DRUG: docetaxel
- DRUG: gemcitabine hydrochloride
Sponsor
Eastern Cooperative Oncology Group
Collaborators